A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy.
Burger DM, Hugen PW, Aarnoutse RE, Dieleman JP, Prins JM, van der Poll T, ten Veen JH, Mulder JW, Meenhorst PL, Blok WL, van der Meer JT, Reiss P, Lange JM.
Burger DM, et al. Among authors: aarnoutse re.
J Acquir Immune Defic Syndr. 2001 Mar 1;26(3):218-24. doi: 10.1097/00042560-200103010-00003.
J Acquir Immune Defic Syndr. 2001.
PMID: 11242194
Free article.
Clinical Trial.